Vaccine stock to climb up to $140 in wave-3
At a weekly time frame, this stock is the next thing to blow out. With phase 3 trials expected in July, the potential of 
MRNA could be huge in upcoming weeks.
With wave-1 and wave-2 already formed, market is now forming wave-3 which may lead the price to possibly $140-160 zone.
(Note: Please ignore the markings for wave-4 and wave-5)
What do you think about this idea? Leave your comments below.
Disclaimer: This is not a financial advise. Please make your independent decisions while making an investment.
MRNA could be huge in upcoming weeks.With wave-1 and wave-2 already formed, market is now forming wave-3 which may lead the price to possibly $140-160 zone.
(Note: Please ignore the markings for wave-4 and wave-5)
What do you think about this idea? Leave your comments below.
Disclaimer: This is not a financial advise. Please make your independent decisions while making an investment.
交易开始
交易手动结束
Trade was closed earlier in August when MRNA made a high of $95.21 and then dropped back to 60s breaking the trend line.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。